| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 The Center for Cardiology and Cardiovascular Biology, University of Connecticut, Farmington, CT, USA
2 Indiana University School of Medicine, Krannert Institute of Cardiology, Indianapolis, IN, USA
3 University of Utah School of Medicine, Salt Lake City, Utah, USA
* To whom correspondence should be addressed. E-mail: bliang{at}uchc.edu.
The P2X4 purinergic receptor (P2X4R) is a ligand-gated ion channel. Its activation
by extracellular ATP results in Ca2+ influx. Transgenic cardiac overexpression of the human P2X4 receptor showed an in vitro phenotype of enhanced basal contractility. The objective here was to determine the in vivo cardiac physiological role of this receptor. Specifically, it tested the hypothesis that this
receptor plays an important role in modulating heart failure progression. Transgenic cardiac overexpression of canine calsequestrin (CSQ) showed hypertrophy, heart failure, and premature death. Crossing the P2X4R mouse with the CSQ mouse more than doubled the lifespan (182 ± 91 days for the binary CSQ/P2X4R mouse, n=35) of the CSQ mouse (71.3 ± 25.4 days, n=50, P<0.0001). The prolonged survival in the binary CSQ/P2X4R mouse was associated with an improved left ventricular weight to body weight ratio and a
restored 
-adrenergic responsiveness. The beneficial phenotype of the binary mouse was not associated with any downregulation of the CSQ level but correlated with improved left ventricular developed pressure and ±dP/dt. The enhanced cardiac performance was manifested in young binary animals and persisted into in older animals. The increased contractility likely underlies the survival benefit from P2X4 receptor overexpression. An increased expression or activation of this receptor may represent a new approach in the therapy of heart failure.
This article has been cited by other articles:
|
|
 |
|
  J. Liu, D. K. Lieu, C. W. Siu, J.-D. Fu, H.-F. Tse, and R. A. Li Facilitated maturation of Ca2+ handling properties of human embryonic stem cell-derived cardiomyocytes by calsequestrin expression Am J Physiol Cell Physiol, July 1, 2009; 297(1): C152 - C159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-B. Shen, R. Shutt, M. Agosto, A. Pappano, and B. T. Liang Reversal of cardiac myocyte dysfunction as a unique mechanism of rescue by P2X4 receptors in cardiomyopathy Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1089 - H1095. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Sonin, S.-Y. Zhou, C. Cronin, T. Sonina, J. Wu, K. A. Jacobson, A. Pappano, and B. T. Liang Role of P2X purinergic receptors in the rescue of ischemic heart failure Am J Physiol Heart Circ Physiol, September 1, 2008; 295(3): H1191 - H1197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Gergs, P. Boknik, W. Schmitz, A. Simm, R.-E. Silber, and J. Neumann A positive inotropic effect of ATP in the human cardiac atrium Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1716 - H1723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-B. Shen, R. Shutt, A. Pappano, and B. T. Liang Characterization and mechanism of P2X receptor-mediated increase in cardiac myocyte contractility Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3056 - H3062. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Jagatheesan, S. Rajan, N. Petrashevskaya, A. Schwartz, G. Boivin, G. M. Arteaga, R. John Solaro, S. B. Liggett, and D. F. Wieczorek Rescue of tropomyosin-induced familial hypertrophic cardiomyopathy mice by transgenesis Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H949 - H958. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |
